https://scholars.lib.ntu.edu.tw/handle/123456789/563569
標題: | Adoption of Regulations for Cell Therapy Development: Linkage Between Taiwan and Japan | 作者: | Tsai T.-H. THAI-YEN LING Lee C.-H. |
公開日期: | 2020 | 卷: | 13 | 期: | 6 | 起(迄)頁: | 1045-1047 | 來源出版物: | Clinical and Translational Science | 摘要: | Although cell-based therapy has become a promising treatment, its practice and evaluation process remain unstandardized. Therefore, Japan initiated a dual-track regulatory framework for cell-based therapy aiming to promote and regulate the therapies to ensure that patients can access safe and effective treatments. Influenced by such pathway, Taiwan adopted the framework and initiated its own cell-based therapy regulation in 2018. This paper discusses how Japan has influenced Taiwan in developing regulations for cell-based therapy. ? 2020 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/563569 | ISSN: | 17528054 | DOI: | 10.1111/cts.12813 | SDG/關鍵字: | adoption; cell therapy; human; Japan; review; Taiwan; biological therapy; health care delivery; health service; international cooperation; Japan; medical technology; medical tourism; organization and management; practice guideline; Taiwan; Biomedical Technology; Cell- and Tissue-Based Therapy; Health Services Accessibility; Health Services Needs and Demand; Humans; International Cooperation; Japan; Medical Tourism; Practice Guidelines as Topic; Taiwan |
顯示於: | 藥理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。